4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-024955
Chief Medical Officer bought 1,508 shares at $32.96 ($49,704)
From the SEC's structured data for this filing
Trades in this filing
Patel Naimish · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-03 | Purchase : show line 1 in the form | +1,508 | $32.96 | $49,704 | 1,508 | D |
| Open-market purchases · 1,508 sh · avg $32.96 · $49,704 | ||||||
Loading xslF345X05/ownership.xml…